WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark GENOSCIENCE PHARMA was filed as Word mark on 02/01/2019 at the World Intellectual Property Organization.
| Trademark form | Word mark |
| File reference | 1466528 |
| Register number | 017939038 |
| Countries | 
|
| Base trademark |
No. 017939038,
December 21, 2018
|
| Application date | February 1, 2019 |
| Expiration date | February 1, 2029 |
Trademark owner
10 Rue d'Iéna
F-13006 Marseille
FR
F-13006 Marseille
FR
Trademark representatives
35 rue Paradis,
BP 30064
FR
goods and services
01
Active chemical ingredients used in the manufacture of
anti-cancer drugs; chemical products intended for
pharmaceutical sciences; chemical additives for use in the
manufacture of pharmaceuticals; preserving agents for the
pharmaceutical industry; antioxidants for the manufacture
of pharmaceutical products; chemical preparations for be
used in the manufacture of pharmaceutical products;
chemical products for biotechnological product development;
enzymes derived from biotechnological processes for
industrial use; chemicals used in biotechnological
manufacturing processes; diagnostic preparations for
scientific or diagnostic reagents research for science or
research; reagents and solvents for sample preparation,
modification and manipulation of cells, as well as for the
implementation of marking methods, separation, isolation,
reproduction and/or cleaning of biopolymers, nucleic acids,
proteins, macromolecules and biologically active substances
for diagnostic use
05
Pharmaceutical preparations; pharmaceutical products;
pharmaceutical substances; pharmaceutical preparations for
cancer treatment; biopharmaceutical products for cancer
treatment; pharmaceutical products for cancer treatment;
pharmaceutical preparations and substances for cancer
prevention; pharmaceutical preparations for the prevention
and treatment of cancer; pharmaceutical compositions and
preparations for cancer prevention and treatment;
biotechnological preparations for medical use; diagnostic
agents for medical use; strips for medical diagnosis;
diagnostic preparations for medical use; diagnostic
preparations for medical use; diagnostic reagents for
medical use; diagnostic substances for medical use;
pharmaceutical medicine products, namely diagnostic products
for sample preparation, modification and manipulation of
cells and for marking, separation, isolation, reproduction
and/or cleaning of biopolymers, nucleic acids, proteins,
macromolecules and biologically active substances; kits
containing products for pharmaceutical medical diagnostic
use
42
Development of new technology on behalf of third parties in
the field of genetics and biotechnology; development tools
in the nature of biotechnological processes for regulating,
modifying and characterizing of disease conditions;
research and development for third parties in the field of
biotechnology; manufacturing and consolidating upon request
of DNA, biological organisms, cells, viruses, pathogens,
special cells which have been genetically modified according
to the specification of third parties for scientific,
medical and laboratory use and for research; gene therapy
services for third parties for scientific research and
product development, namely DNA, biological organisms,
cells, viruses, pathogens and special cells which have been
genetically modified for scientific and medical use and for
research; scientific and technological services as well as
research and design services relating thereto; industrial
analysis and research services; research and development of
anti-cancer drugs; development of pharmaceutical
preparations and medicines; development of pharmaceutical
products; development of chemical compounds; research and
development of chemical compounds for therapeutic use;
development of anti-cancer drugs; evaluation of
pharmaceutical products; research in the field of
pharmaceutical products; research and development in the
field of anti-cancer drugs; pharmaceutical research and
development services; pharmaceutical research; carrying out
clinical trials for pharmaceutical products; conducting
clinical trials for cancer treatment; provision of
information concerning the results of clinical trials for
pharmaceutical products; laboratory research services in
the field of pharmaceuticals; laboratory research services
for cancer treatment; testing, inspection and research
services in the field of pharmaceuticals; testing,
inspection and research for cancer treatment;
biotechnological research services; preparation of reports
in the field of biotechnology; research and development in
the field of biotechnology; services provided by consultants
in the field of biotechnology; providing information in
relation to scientific research in the biochemical and
biotechnological fields; design and development of
diagnostic apparatus
44
Medical analysis services for diagnosing cancer; RNA or DNA
analysis for cancer diagnosis and prognosis; medical
analysis services for cancer diagnosis and prognosis;
colorectal cancer screening services; services for
diagnosing diseases; medical diagnosis services; medical
testing for the diagnosis and treatment of persons; medical
analysis services for cancer diagnosis; medical diagnostic
services [testing and analysis]
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| January 15, 2021 | 2021/3 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| December 16, 2020 | 2020/51 Gaz | US | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| July 23, 2020 | 2020/30 Gaz | JP | Rejection |
| August 16, 2019 | 2019/37 Gaz | RAW: Limitation | |
| July 3, 2019 | 2019/29 Gaz | CN | Rejection |
| June 24, 2019 | 2019/26 Gaz | US | Rejection |
| February 1, 2019 | 2019/18 Gaz | EM | Registration |
ID: 141466528